Pancreatic Cancer Stage IV Clinical Trials

18 clinical trials for Pancreatic Cancer Stage IV across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer — RECRUITING
• SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells — RECRUITING · PHASE1
• Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer — RECRUITING · PHASE1
• Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer — RECRUITING · PHASE2
• Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer — RECRUITING · PHASE3
• Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) — ACTIVE_NOT_RECRUITING · PHASE1
• Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer — COMPLETED · PHASE2
• Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients with Unresectable Pancreatic Cancer. — ACTIVE_NOT_RECRUITING · PHASE1
• Evaluate Efficacy of Devimistat in Combination With mFFX in 2nd Line Patients With Metastatic Pancreatic Cancer — WITHDRAWN · PHASE2
• SHR- 1210 Combined With Paclitaxel (Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer — COMPLETED · NA
• A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer — OTHER · PHASE3
• Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer — COMPLETED · PHASE2
• PanDox: Targeted Doxorubicin in Pancreatic Tumours — WITHDRAWN · PHASE1
• Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer — COMPLETED · PHASE1
• Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells — OTHER
• Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer — TERMINATED
• Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic Cancer — OTHER · PHASE1
• IORT Versus CCRT for Pancreatic Cancer — OTHER · NA

Refine this search